Výsledky vyhledávání - "Isabel Kloer"

A Post Hoc Holter ECG Analysis of Olodaterol and Formoterol in Moderate-to-Very-Severe COPD

Autor: Ulrich Bothner, Alberto de la Hoz, Stefan Andreas, Matthias Trampisch, Isabel Kloer, Peter Alter

Publikováno v: International Journal of Chronic Obstructive Pulmonary Disease. 15:1955-1965

Background Patients with chronic obstructive pulmonary disease (COPD) are at risk of developing cardiac arrhythmias and elevated heart rate. A theoretical mechanistic association based on the interaction of long-acting β2-agonists (LABAs) with adren

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::071cbfb85133a5d2427ec86e3a5b5427
https://doi.org/10.2147/copd.s246353

Zobrazit plný text záznamu

No Influence on Cardiac Arrhythmia or Heart Rate from Long-Term Treatment with Tiotropium/Olodaterol versus Monocomponents by Holter ECG Analysis in Patients with Moderate-to-Very-Severe COPD

Autor: Ulrich Bothner, Stefan Andreas, Isabel Kloer, Peter Alter, Alberto de la Hoz, Matthias Trampisch

Publikováno v: International Journal of Chronic Obstructive Pulmonary Disease

Stefan Andreas,1,2 Ulrich Bothner,3 Alberto de la Hoz,3 Isabel Kloer,3 Matthias Trampisch,3 Peter Alter4 1Department of Cardiology and Pneumology, University Medical Centre Göttingen, Göttingen, Germany; 2LungClinic Immenhausen, Immenhausen, German

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13842046f4e9a67d0b09003c17e35ca8
https://doi.org/10.2147/copd.s246350

Zobrazit plný text záznamu

Long-term safety of tiotropium/olodaterol in older patients with moderate-to-very-severe COPD in the TONADO® studies

Autor: Roland Buhl, Matthias Trampisch, Ulrich Bothner, Gary T. Ferguson, François Maltais, Jill P. Karpel, Isabel Kloer

Publikováno v: NPJ Primary Care Respiratory Medicine

Older patients with chronic obstructive pulmonary disease (COPD) may be at increased risk of adverse events (AEs) due to decreased protective organ function and increased comorbidities. TONADO® 1 + 2 were replicate, randomized, double-blind, paralle

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63f5df8322c776310060c95a37dc5b9a
https://doi.org/10.1038/s41533-020-00212-w

Zobrazit plný text záznamu

Long-term safety of tiotropium/olodaterol Respimat® in patients with moderate-to-very severe COPD and renal impairment in the TONADO® studies

Autor: Ulrich Bothner, Matthias Trampisch, Eric Derom, Roland Buhl, Isabel Kloer, Craig Laforce

Publikováno v: International Journal of Chronic Obstructive Pulmonary Disease. 13:1819-1831

Introduction: The safety, lung function efficacy, and symptomatic benefits of combined tiotropium and olodaterol in patients with COPD were established in the 1-year TONADO (R) studies (NCT01431274; NCT01431287). As tiotropium is predominantly excret

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e5d52b30435b277f6849b924ca41d497
https://doi.org/10.2147/copd.s161489

Zobrazit plný text záznamu

Holter ECG-based arrhythmia and heart rate analysis in patients with COPD receiving a fixed-dose combination of tiotropium/olodaterol versus its monocomponents

Autor: Matthias Trampisch, Stefan Andreas, Isabel Kloer, A. de la Hoz, Ulrich Bothner, Peter Alter

Publikováno v: 60. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V..

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::179128d1d6c51a9c83fcc851c340fe7b
https://doi.org/10.1055/s-0039-1678231

Zobrazit plný text záznamu

Late Breaking Abstract - Holter ECG-based arrhythmia and heart rate analysis in patients with COPD receiving a fixed-dose combination of tiotropium/olodaterol versus its monocomponents

Autor: Ulrich Bothner, Matthias Trampisch, Alberto de la Hoz, Stefan Andreas, Peter Alter, Isabel Kloer

Publikováno v: Airway pharmacology and treatment.

Introduction: Patients with COPD frequently exhibit cardiovascular comorbidities and are at risk of cardiac arrhythmias. To evaluate potential class effects of long-acting muscarinic antagonists and long-acting β2-agonists on an increased arrhythmia

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9137e56fe967847d6c96dc0c87422721
https://doi.org/10.1183/13993003.congress-2018.oa2126

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání